This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Alexion Pharmaceuticals, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovative Contributions of Meghan Dewitt
Introduction
Meghan Dewitt is a notable inventor based in Madison, CT (US). She has made significant strides in the field of biotechnology, particularly through her work at Alexion Pharmaceuticals, Inc. Her innovative approach has led to the development of a unique method for producing recombinant alkaline phosphatase.
Latest Patents
Meghan holds a patent for a "Method for producing recombinant alkaline phosphatase." This method involves the control of production parameters, specifically the harvest clarified culture fluid (HCCF) and filtration pool (UFDF), to achieve a defined total sialic acid content. This innovation is crucial for enhancing the efficiency and effectiveness of biochemical processes.
Career Highlights
Throughout her career, Meghan has demonstrated a commitment to advancing biopharmaceutical technologies. Her work at Alexion Pharmaceuticals, Inc. has positioned her as a key player in the industry, contributing to the development of therapies that improve patient outcomes.
Collaborations
Meghan collaborates with talented professionals such as Rahul Godawat and Siguang Sui. These partnerships foster a dynamic environment for innovation and problem-solving within the company.
Conclusion
Meghan Dewitt's contributions to biotechnology exemplify the impact of innovative thinking in the pharmaceutical industry. Her patent and collaborative efforts highlight her dedication to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile